Cardiac arrest & resuscitation

Predictive value of soluble CD59 for poor 28-day neurological prognosis and all-cause mortality in patients after cardiopulmonary resuscitation: a prospective observatory study

J Intensive CarePublished Prospective observational study

Authors' conclusion

The elevated serum level of sCD59 was positively correlated with disease severity after ROSC. Moreover, serum sCD59 could have good predictive values for the poor 28-day neurological prognosis and all-cause mortality in patients after ROSC.

Study context

Population
Patients after restoration of spontaneous circulation (ROSC) following CPR68 patients after ROSC
Participants
23 / 45 / 20
Exposure
Survivors vs non-survivors at 28 days after ROSC; healthy volunteers as controls
  • Survivorsn = 23reference
  • Non-survivorsn = 45
  • Controlsn = 20
Outcome
Predictive value of serum sCD59 for poor neurological prognosis (cerebral performance category 3-5) and all-cause mortality
Follow-up
28 days

Main finding

As reported in the abstract

Prediction by serum sCD59 on day 3 after ROSC

AUC of day-3 sCD59 for poor 28-day neurological prognosis

0.862

95% CI 0.678–0.960

AUC of day-3 sCD59 for 28-day all-cause mortality

0.891

95% CI 0.769–0.962

Observational data: associations, not effects.

Further findings

Serum complement components, inflammatory mediators and neurological damage biomarkers · first week after ROSC

sCD59, sC5b-9, C5a, C3a, C3b, C1q, MBL, Bb, tumor necrosis factor (TNF)-α, IL-6, neuron-specific enolase (NSE) and S100β significantly elevated after ROSC vs healthy volunteers; significantly higher in non-survivors vs survivors except C1q and MBL

Correlations of serum sCD59

Positively correlated with sC5b-9, TNF-α, IL-6, NSE, S100β, SOFA and APACHE II scores

Original publication

Predictive value of soluble CD59 for poor 28-day neurological prognosis and all-cause mortality in patients after cardiopulmonary resuscitation: a prospective observatory study. J Intensive Care. Published 2 February 2023. doi:10.1186/s40560-023-00653-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.